<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher">global-journal-of-science-frontier-research-c-biological-science</journal-id>
<journal-title-group>
<journal-title>Global Journal of Science Frontier Research - C: Biological Science</journal-title>
</journal-title-group>
<issn publication-format="print">0975-5896</issn>
<issn publication-format="electronic">2249-4626</issn>
<publisher><publisher-name>Global Journals Publishing Group Incorporated</publisher-name></publisher>
<self-uri xlink:href="https://globaljournals.org/journal-seo-export/jats/58154.xml" />
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">58154</article-id>
<title-group>
<article-title>Incidence of Serious AEFI Linked to Reactions to the Vaccine Product in weakly Immunized Health Areas, Case of the ZS of Kabinda, Province of Lomami, DRC, November 2019</article-title>
<subtitle>No Significant Sex Difference in AEFI among Children</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Leon</surname><given-names>Kinuani Mbulu</given-names></name><xref ref-type="aff" rid="aff1" />
</contrib>
<contrib contrib-type="author"><name><surname>Aliocha</surname><given-names>Nkodila Natuhoyila</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Gaye</surname><given-names>Abou Beckr</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Moise</surname><given-names>Yapi</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Moise</surname><given-names>Badjiok</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Piripiri</surname><given-names>Lina</given-names></name></contrib>
</contrib-group>
<aff id="aff1">UNITED STATES</aff>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2021-11-25">
<day>25</day>
<month>11</month>
<year>2021</year>
</pub-date>
<volume>21</volume>
<issue>C5</issue>
<fpage>1</fpage>
<lpage>5</lpage>
<abstract><p>Abstract not found</p></abstract>
<self-uri content-type="pdf" xlink:href="https://globaljournals.org/GJSFR_Volume21/1-Incidence-of-Serious-AEFI.pdf" />
<self-uri content-type="html" xlink:href="https://globaljournals.org/scholarly-articles/incidence-of-serious-aefi-linked-to-reactions-to-the-vaccine-product-in-weakly-immunized-health-areas-case-of-the-zs-of-kabinda-province-of-lomami-drc-november-2019/" />
</article-meta>
</front>
<body>
<sec>
<title>Full Text</title>
<p>Vaccines are considered safe, effective in disease prevention and cost-effective [1, 2]. Reason for the need to expand and maintain high immunization coverage in order to maintain effective immunity [3-5]. But this vaccine leads to the likelihood of occurrence of adverse events following vaccination (AEFI), since vaccines are pharmacological products and are not exempt from causing adverse events in some people [1, 3-5].</p>
</sec>
</body>
</article>